March 22, 2021
Hagar Elgendy, a fourth-year medical student, shared her Match Day experience with Cincinnati TV journalist Kristyn Hartman of WCPO. Elgendy will spend the next three years training in physical medicine and rehabilitation at UNC Hospitals in Chapel Hill, North Carolina.
March 24, 2021
Jaasiel Chapman of the Division of Infectious Diseases at the UC College of Medicine was widely quoted in an article on the reluctance of black women to take pre-exposure prophylaxis, also known as PrEP, the preventative medication used to reduce the spread of HIV/AIDS.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.
March 15, 2021
COVID-19 can lead to inflammation of the blood vessels in the lungs and other key organs, says Richard Becker, MD, a UC cardiologist and director of the UC Heart, Lung and Vascular Institute. Vasculitis is a contributor to acute respiratory syndrome in COVID-19 patients.
March 15, 2021
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, was featured as an expert source in a story on Medscape about animal model research showing that a new adjuvant, or ingredient, added to COVID-19 vaccines has shown promise for its ability to deliver the vaccine directly into lymph nodes.
March 16, 2021
Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine is widely quoted in an article on Livestrong.com about the potential health challenges posed by snoring. She says there is evidence that loud snoring could lead to stroke.
March 22, 2021
Timothy Pritts, MD, PhD, chief of the section of general surgery and vice chair of clinical operations at the UC College of Medicine, weighs in on new study about early-career acute care surgeons and the need for mentorship to improve patient outcomes.
March 24, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources quoted in an article for Reuters Health on a study showing that in patients with moderate-severe COVID-19, recombinant super-compound interferon plus baseline antivirals was associated with a shorter time to clinical improvement than the same regimen using traditional interferon-alpha in an exploratory trial in China. Fichtenbaum said a lot more data and proof is needed before he would use this. And the lack of a control group that got just standard of care is a big weakness of this study.
March 15, 2021
University of Cincinnati researchers say for the first time they have a visual correlation between the severity of COVID-19 in the lungs and the effect on patients' brains, WVXU-FM reports.
March 29, 2021
Jonathan Bernstein, MD, University of Cincinnati allergies, speaks with Reuters Health about a new study suggesting hormone replacement therapy increasing the risk of severe asthma in asthmatic women.